Companies / IBX

IMAGION BIOSYSTEMS LIMITED

ASX:IBXHealth Care Equipment & Services
539.9M shares on issueASX (delayed) · as of 28 July 2026$0.012price · delayed$6.5Mmarket cap · indicative
F
Dilution grade

Share count grew 1443% in 24 months; runway 2–4 quarters; 6 cash raises in 24 months

Cash runway2.2 quarters of funding
Share-count growth (24m)1442.8%
Raise cadence (24m)6 cash raises
Options & rights overhang228.1% of shares
In-the-money supply0.0% of shares
Pending proposed issuesopen proposed issue (Appendix 3B)

IMAGION BIOSYSTEMS LIMITED's ordinary share count grew 1442.8% between July 2024 and July 2026, to 540M shares. The company raised capital six times in that period for total disclosed proceeds of A$17.2M, most recently a A$3.8M placement in June 2026. Options and rights on issue could convert into 1.23B new shares, equal to 228.1% of the current share count, of which 0% are in the money at the current share price; the nearest expiry falls in August 2026. At the March 2026 quarter the company reported A$2.8M in available cash, about 2.2 quarters of funding at its recent spending rate. Four proposed securities issues (Appendix 3B) are pending, with the nearest expected issue date in August 2026.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
228.1%
Max option dilution
0.0%
ITM option dilution
4
Raises · last 12 months
2.2 qtrs
Cash cover · 2–4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 539.9M per ASX (delayed) (28 July 2026).
149.1M292.6M436.0MDec 24Sept 25July 26Cash raise · 22 June 2026Cash raise · 16 Apr 2026Cash raise · 30 July 2025Cash raise · 30 July 2025

Cash runway

2.2 qtrs
Two to four quarters of funding at the recent spend rate.
$2.8M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
1 July 20262A · quoted issueIBX : ORDINARY FULLY PAID539.9MAppendix 2A
25 June 20263G · unquotedIBX : ORDINARY FULLY PAID490.6MAppendix 3G
12 June 20263H · cancellationIBX : ORDINARY FULLY PAID490.6MAppendix 3H
28 May 20263H · cancellationIBX : ORDINARY FULLY PAID490.6MAppendix 3H
4 May 20263H · cancellationIBX : ORDINARY FULLY PAID490.6MAppendix 3H
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

6 cash raises in the last 24 months · 4 in the last 12 months

$3.8M
Placement
22 June 2026 ACTIVE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

4 proposed issues pending — Appendix 3B lodged, securities not yet issued. New shares from these issues are not in the counts above until quoted.
Paid plan
Pending issue detail
Size, price, fees, broker and placement-capacity usage for each pending issue.
Join the waitlist

Options & convertible securities

228.1%
Total overhang · of current shares
0.0%
In the money · at current price
1.23B
Potential new shares
Aug 2026
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
25 June 2026Dr Nina WebsterOther565k——3Y notice
25 June 2026Brett MitchellOther5.9M1.9M—3Y notice
25 June 2026Robert Romeo ProulxOther4.5M6.0M—3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

28 July 2026Proposed issue of securities - IBX
28 July 2026Non-Dilutive Short-Term Funding Secured
7 July 2026Notice of General Meeting/Proxy Form
6 July 2026Imagion Extends Collaboration with Siemens Healthineers
1 July 2026Cleansing Notice
1 July 2026Application for quotation of securities - IBX
1 July 2026Change of Director's Interest Notices - RP, BM, NW
25 June 2026Notification regarding unquoted securities - IBX
25 June 2026Update - Proposed issue of securities - IBX
24 June 2026Proposed issue of securities - IBX
24 June 2026Proposed issue of securities - IBX
24 June 2026Proposed issue of securities - IBX
24 June 2026$PIBX Secures Firm Commitments for $3.75m for Clinical Trial
22 June 2026$PTrading Halt
12 June 2026Notification of cessation of securities - IBX
1 June 2026$PImagion Biosystems Receives IND Clearance from US FDA
28 May 2026Notification of cessation of securities - IBX
26 May 2026Results of Annual General Meeting
25 May 2026Investor Presentation
25 May 2026IBX Chairman's AGM Address

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.